2BB score and signals
Black Diamond Therapeutics, Inc.’s current 2BB score is 17 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 21 | Weak |
| Quality | 40 | Normal |
| Risk | 35 | Low |
Black Diamond Therapeutics, Inc. (BDTX) Stock Score & Signals
Black Diamond Therapeutics, Inc. (BDTX) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 17 out of 100.
Company facts
| Founded | 2014 |
| Employees | 21 |
| 52-week range | $1.60 – $4.94 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-15 | — | -0.1984 | — | $0.00 |
| 2026-11-04 | — | -0.1998 | — | $0.00 |
| 2026-08-06 | — | -0.1993 | — | $0.00 |
| 2026-05-07 | -0.16 | -0.1884 | $0.00 | $0.00 |